Literature DB >> 16955535

Cross-over trials in Statistics in Medicine: the first '25' years.

Stephen Senn1.   

Abstract

Papers on cross-over trials that have appeared in the first 25 years of Statistics in Medicine are reviewed. Papers on bioequivalence are also considered. After a brief statistical summary, individual papers are discussed under seven headings: 1. The two-stage analysis of AB/BA trials, 2. Baselines, 3. Binary and categorical data, 4. Survival data, 5. Modelling carry-over, 6. Bioequivalence and 7. Components of variation. Finally, a brief assessment of the importance in this field of Statistics in Medicine is given.

Entities:  

Mesh：

Year:  2006        PMID： 16955535     DOI： 10.1002/sim.2706

Source DB:  PubMed          Journal:  Stat Med        ISSN： 0277-6715            Impact factor:   2.373


  13 in total

1.  A hierarchical rank test for crossover trials with censored data.

Authors:  Erica Brittain; Dean Follmann
Journal:  Stat Med       Date:  2011-12-05       Impact factor: 2.373

2.  Assessing the Accuracy of Continuous Glucose Monitoring (CGM) Calibrated With Capillary Values Using Capillary or Venous Glucose Levels as a Reference.

Authors:  Mervi Andelin; Jort Kropff; Viktorija Matuleviciene; Jeffrey I Joseph; Stig Attvall; Elvar Theodorsson; Irl B Hirsch; Henrik Imberg; Sofia Dahlqvist; David Klonoff; Börje Haraldsson; J Hans DeVries; Marcus Lind
Journal:  J Diabetes Sci Technol       Date:  2016-06-28

3.  Hippocampal volume in healthy controls given 3-day stress doses of hydrocortisone.

Authors:  E Sherwood Brown; Haekyung Jeon-Slaughter; Hanzhang Lu; Rhoda Jamadar; Sruthy Issac; Mujeeb Shad; Daren Denniston; Carol Tamminga; Alyson Nakamura; Binu P Thomas
Journal:  Neuropsychopharmacology       Date:  2015-03-13       Impact factor: 7.853

4.  Effects of high and normal soyprotein breakfasts on satiety and subsequent energy intake, including amino acid and 'satiety' hormone responses.

Authors:  Margriet A B Veldhorst; Arie G Nieuwenhuizen; Ananda Hochstenbach-Waelen; Klaas R Westerterp; Marielle P K J Engelen; Robert-Jan M Brummer; Nicolaas E P Deutz; Margriet S Westerterp-Plantenga
Journal:  Eur J Nutr       Date:  2009-01-13       Impact factor: 5.614

5.  Treatment Heterogeneity and Individual Qualitative Interaction.

Authors:  Robert S Poulson; Gary L Gadbury; David B Allison
Journal:  Am Stat       Date:  2012-06-12       Impact factor: 8.710

6.  Digital photography as an educational food logging tool in obese patients with type 2 diabetes: lessons learned from a randomized, crossover pilot trial.

Authors:  Brett J Ehrmann; Robert M Anderson; Gretchen A Piatt; Martha M Funnell; Hira Rashid; Kerby Shedden; Liselle Douyon
Journal:  Diabetes Educ       Date:  2013-10-29       Impact factor: 2.140

7.  Testing for carryover effects after cessation of treatments: a design approach.

Authors:  S Gwynn Sturdevant; Thomas Lumley
Journal:  BMC Med Res Methodol       Date:  2016-08-02       Impact factor: 4.615

8.  Understanding Variation in Sets of N-of-1 Trials.

Authors:  Artur Araujo; Steven Julious; Stephen Senn
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

9.  Effects of exenatide alone and in combination with daclizumab on beta-cell function in long-standing type 1 diabetes.

Authors:  Kristina I Rother; Lisa M Spain; Robert A Wesley; Benigno J Digon; Alain Baron; Kim Chen; Patric Nelson; H-Michael Dosch; Jerry P Palmer; Barbara Brooks-Worrell; Michael Ring; David M Harlan
Journal:  Diabetes Care       Date:  2009-10-06       Impact factor: 19.112

10.  Reduction of self-perceived discomforts in critically ill patients in French intensive care units: study protocol for a cluster-randomized controlled trial.

Authors:  Pierre Kalfon; Olivier Mimoz; Anderson Loundou; Marie-Agnès Geantot; Nathalie Revel; Isabelle Villard; Julien Amour; Elie Azoulay; Maïté Garrouste-Orgeas; Claude Martin; Tarek Sharshar; Karine Baumstarck; Pascal Auquier
Journal:  Trials       Date:  2016-02-16       Impact factor: 2.279
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.